Aptose Biosciences has postponed its special meeting of shareholders to approve the acquisition by Hanmi. The meeting was rescheduled due to pending final clearance from the SEC. The new date for the special meeting will be announced soon. Shareholders are advised to stay updated for further details. This decision comes as both companies work towards finalizing the acquisition, which is a significant development in the biotech industry. Stay tuned for more information on this important transaction.